EBN NOTEBOOK
Economic evaluation of healthcare technologies using primary research
Department of Health Sciences, University of York; York, UK
| The first 150 words of the full text of this article appear below. |
Clinicians and policy makers are often required to make difficult decisions regarding which health technologies they use. Increasingly, government bodies, such as the National Institute of Health and Clinical Excellence (NICE) in the UK, produce national clinical guidelines and technology assessments to direct practice.1 These assessments often consider not only the benefits conferred by alternate treatment choices but also the costs.
It is vital that clinical practitioners have a clear understanding of why economic evaluations are needed, what the results of such evaluations mean, and how these findings can inform allocation decisions. We will begin by introducing key ideas and then illustrate these ideas with examples.
Central government or federally funded services must deliver health care within fixed and limited budgets (see box). Decisions made to spend money in one way will incur an opportunity cost in terms of investment in other health services that are foregone. For example, investment
This article has been cited by other articles:
-
Soares, M., Dumville, J. C
(2008). Critical appraisal of cost-effectiveness and cost-utility studies in health care. Evid. Based Nurs.
11: 99-102
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
